Our clients trust our protocols for FDA pre-market product approvals, backed by over 50 years as an industry-leading research provider. Our expert team works with you to customize comprehensive cannabis data collection solutions that deliver reliable, actionable data.
Bring Your Product
To Market Faster
Supporting a Broad Range of Testing
Actual Use Tests (AUT)
Regulated Data Collection Expertise
Extensive experience with
successful PMA submissions
Our expertise in recruiting subjects provides unparalleled access to your intended audience with secure data as mandated by the FDA.
Rigorous project execution
Our team works closely with you to develop or follow clinical study protocols, manage interactions with the IRB, and deliver quality results nationwide efficiently to support your FDA reporting needs.
Connect with Your Consumers
Our deeply profiled proprietary panel of opted-in consumers and patients powers our ability to connect you with your target audience for your important cannabis studies.
At Schlesinger Clinical Research, our expertise in participant recruiting and clinical project execution provides unparalleled access to your target audiences for data you can trust. Certified teams and 30 proprietary sites across key markets in the US, together with one Clinical Project leader, provides study consistency and quality to your timeline.